These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25695302)

  • 1. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
    Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
    Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
    Desimmie BA; Delviks-Frankenberrry KA; Burdick RC; Qi D; Izumi T; Pathak VK
    J Mol Biol; 2014 Mar; 426(6):1220-45. PubMed ID: 24189052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cellular restriction factors that target HIV-1 replication.
    Strebel K; Luban J; Jeang KT
    BMC Med; 2009 Sep; 7():48. PubMed ID: 19758442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
    Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
    Front Immunol; 2018; 9():1839. PubMed ID: 30135687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins.
    Farrow MA; Sheehy AM
    Future Microbiol; 2008 Apr; 3(2):145-54. PubMed ID: 18366335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
    Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
    J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G.
    Sugiyama R; Abe M; Nishitsuji H; Murakami Y; Takeuchi H; Takaku H
    Antiviral Res; 2013 Sep; 99(3):307-11. PubMed ID: 23831493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system.
    Argyris EG; Acheampong E; Wang F; Huang J; Chen K; Mukhtar M; Zhang H
    Virology; 2007 Oct; 367(2):440-51. PubMed ID: 17631933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
    Chiu YL; Greene WC
    Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
    Colomer-Lluch M; Ruiz A; Moris A; Prado JG
    Front Immunol; 2018; 9():2876. PubMed ID: 30574147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity and HIV-1 infection.
    Lehner T; Wang Y; Whittall T; Seidl T
    Adv Dent Res; 2011 Apr; 23(1):19-22. PubMed ID: 21441475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC family proteins: novel antiviral innate immunity.
    Takaori-Kondo A
    Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the study of HIV-1 Vif and related inhibitors].
    Li ZY; Zhan P; Liu XY
    Yao Xue Xue Bao; 2010 Jun; 45(6):684-93. PubMed ID: 20939174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel host restriction factors implicated in HIV-1 replication.
    Ghimire D; Rai M; Gaur R
    J Gen Virol; 2018 Apr; 99(4):435-446. PubMed ID: 29465030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research methods of anti-HIV-1 inhibitors targeting at Vif-APOBEC3G axis].
    Qiao X; Zhang W; Li Z; Zeng Y
    Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(6):806-9. PubMed ID: 21710755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing immunity to HIV through APOBEC.
    Harris RS
    Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
    [No Abstract]   [Full Text] [Related]  

  • 20. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
    Kaiser SM; Emerman M
    J Virol; 2006 Jan; 80(2):875-82. PubMed ID: 16378989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.